Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer

Journal of the Medical Association of Thailand

Volumn 83, Issue 4, 2000, Pages 383-391

  Chantapet, Pranee ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CEA; CYFRA 21 1; Diagnosis; Non small cell lung cancer; Tumour marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; KERATIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0034168739     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Riantawan P, Tungsagunwattana S, Subhannachart P, Yodtasurodom C. Histologic types, staging, resectability, and smoking among Thai patients with lung cancer. J Med Assoc Thai 1999;82: 121-5.
2. Riantawan P, Chaisuksuwan R, Titayanpong A. Survival among patients with advanced non-small cell lung cancer receiving supportive care. J Med Assoc Thai 1999; 82:336-40.
3. Riantawan P, Koanantakool T, Chotivatanapong T; Wongsagiem M. Survival analysis of Thai patients with non-small cell lung cancer undergoing surgical resection. J Med Assoc Thai 1999; 82: 552-7.
4. Seregni E, Botti C, Bogni A, Bombardieri E. Tumour marker evaluation in patients with lung cancer. Scand J Clin Lab Invest 1995 ; 55 (Suppl 221)67-71.